Literature DB >> 24807067

Image-guided high-dose-rate brachytherapy in inoperable endometrial cancer.

P Dankulchai1, J Petsuksiri, Y Chansilpa, P J Hoskin.   

Abstract

Inoperable endometrial cancer may be treated with curative aim using radical radiotherapy alone. The radiation techniques are external beam radiotherapy (EBRT) alone, EBRT plus brachytherapy and brachytherapy alone. Recently, high-dose-rate brachytherapy has been used instead of low-dose-rate brachytherapy. Image-guided brachytherapy enables sufficient coverage of tumour and reduction of dose to the organs at risk, thus increasing the therapeutic ratio of treatment. Local control rates with three-dimensional brachytherapy appear better than with conventional techniques (about 90-100% and 70-90%, respectively).

Entities:  

Mesh:

Year:  2014        PMID: 24807067      PMCID: PMC4075585          DOI: 10.1259/bjr.20140018

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  49 in total

1.  The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium.

Authors:  S Nag; B Erickson; S Parikh; N Gupta; M Varia; G Glasgow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-10-01       Impact factor: 7.038

2.  American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles.

Authors:  Akila N Viswanathan; Bruce Thomadsen
Journal:  Brachytherapy       Date:  2012 Jan-Feb       Impact factor: 2.362

3.  American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy.

Authors:  Akila N Viswanathan; Sushil Beriwal; Jennifer F De Los Santos; D Jeffrey Demanes; David Gaffney; Jorgen Hansen; Ellen Jones; Christian Kirisits; Bruce Thomadsen; Beth Erickson
Journal:  Brachytherapy       Date:  2012 Jan-Feb       Impact factor: 2.362

Review 4.  Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques.

Authors:  I S Haldorsen; H B Salvesen
Journal:  Clin Radiol       Date:  2011-11-25       Impact factor: 2.350

Review 5.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

Review 6.  [Endometrial cancer imaging].

Authors:  Sophie Taïeb; Nathalie Rocourt; Fabrice Narducci; Luc Ceugnart
Journal:  Bull Cancer       Date:  2012-01       Impact factor: 1.276

7.  Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.

Authors:  C L Creutzberg; W L van Putten; P C Koper; M L Lybeert; J J Jobsen; C C Wárlám-Rodenhuis; K A De Winter; L C Lutgens; A C van den Bergh; E van de Steen-Banasik; H Beerman; M van Lent
Journal:  Lancet       Date:  2000-04-22       Impact factor: 79.321

8.  Dose volume analysis of radiotherapy for inoperable patients with stage I-II endometrial carcinoma.

Authors:  Yu Ohkubo; Shingo Kato; Hiroki Kiyohara; Ichiro Tsuruoka; Tomoaki Tamaki; Shin-ei Noda; Tatsuya Ohno; Takashi Nakano
Journal:  J Radiat Res       Date:  2011-08-20       Impact factor: 2.724

9.  Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.

Authors:  Freddie Bray; Ahmedin Jemal; Nathan Grey; Jacques Ferlay; David Forman
Journal:  Lancet Oncol       Date:  2012-06-01       Impact factor: 41.316

10.  A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.

Authors:  Henry M Keys; James A Roberts; Virginia L Brunetto; Richard J Zaino; Nick M Spirtos; Jeffrey D Bloss; Andrew Pearlman; Mitchell A Maiman; Jeffrey G Bell
Journal:  Gynecol Oncol       Date:  2004-03       Impact factor: 5.482

View more
  8 in total

1.  Clinical assessment of 252Californium neutron intracavitary brachytherapy using a two-channel Y applicator combined with external beam radiotherapy for endometrial cancer.

Authors:  Qian Zhou; Cheng Tang; Ke-Wei Zhao; Yan-Li Xiong; Shu Chen; Wen-Jing Xu; Xin Lei
Journal:  Clinics (Sao Paulo)       Date:  2016-01       Impact factor: 2.365

2.  Interfraction Variations in Organ Filling and Their Impact on Dosimetry in CT Image Based HDR Intracavitary Brachytherapy.

Authors:  Ramya Rangarajan
Journal:  J Med Phys       Date:  2018 Jan-Mar

3.  Definitive three-dimensional high-dose-rate brachytherapy for inoperable endometrial cancer.

Authors:  Lorena Draghini; Ernesto Maranzano; Michelina Casale; Fabio Trippa; Paola Anselmo; Fabio Arcidiacono; Stefania Fabiani; Marco Italiani; Luigia Chirico; Marco Muti
Journal:  J Contemp Brachytherapy       Date:  2017-04-27

4.  Carbon-ion radiotherapy for inoperable endometrial carcinoma.

Authors:  Daisuke Irie; Noriyuki Okonogi; Masaru Wakatsuki; Shingo Kato; Tatsuya Ohno; Kumiko Karasawa; Hiroki Kiyohara; Daijiro Kobayashi; Hiroshi Tsuji; Takashi Nakano; Tadashi Kamada; Makio Shozu
Journal:  J Radiat Res       Date:  2018-05-01       Impact factor: 2.724

5.  Brachy-ing Unresectable Endometrial Cancers with Magnetic Resonance Guidance.

Authors:  Jessica L Conway; Jelena Lukovic; Stephane Laframboise; Sarah E Ferguson; Kathy Han
Journal:  Cureus       Date:  2018-03-05

6.  Inter-Fractional Variations in Volume and Radiation Dose to the Organs at Risk, High-Risk Clinical Target Volume and Implication of Image-Guided Adaptive Planning During Intracavitary Brachytherapy of Carcinoma Cervix.

Authors:  Gurubasappa Patil; Kiran Kumar Br; Geeta Narayanan
Journal:  Cureus       Date:  2022-01-22

7.  Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy.

Authors:  Zahra Siavashpour; Mahmoud Reza Aghamiri; Ramin Jaberi; Hamid Reza Dehghan Manshadi; Reza Ghaderi; Christian Kirisits
Journal:  J Contemp Brachytherapy       Date:  2016-04-29

8.  Medically unfit women with early-stage endometrial cancer treated with the levonorgestrel intrauterine system.

Authors:  Manolis Nikolopoulos; Michelle A L Godfrey; Rekha Wuntakal
Journal:  Obstet Gynecol Sci       Date:  2020-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.